Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2018 台湾多学科共识：痛风及高尿酸血症的管理

2018-01-24 台湾多学科工作组（统称） Int J Rheum Dis. 2018 Jan 24.

痛风高尿酸血症

痛风是一种炎症性疾病，主要表现为在关节、软骨、滑膜囊、肌腱或软组织处沉积单钠晶体。本文主要基于台湾当地流行病学以及最新临床实践和台湾痛风以及高尿酸血症管理指南提出最新多学科专家共识。

中文标题：

2018 台湾多学科共识：痛风及高尿酸血症的管理

英文标题：

Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.

发布机构：

台湾多学科工作组（统称）

发布日期：

2018-01-24

简要介绍：

痛风是一种炎症性疾病，主要表现为在关节、软骨、滑膜囊、肌腱或软组织处沉积单钠晶体。本文主要基于台湾当地流行病学以及最新临床实践和台湾痛风以及高尿酸血症管理指南提出最新多学科专家共识。

拓展指南：与痛风相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 台湾多学科共识：痛风及高尿酸血症的管理)] GetToolGuiderByIdResponse(projectId=1, id=8efc91c0015a94bd, title=2018 台湾多学科共识：痛风及高尿酸血症的管理, enTitle=Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan., guiderFrom=Int J Rheum Dis. 2018 Jan 24., authorId=null, author=, summary=痛风是一种炎症性疾病，主要表现为在关节、软骨、滑膜囊、肌腱或软组织处沉积单钠晶体。本文主要基于台湾当地流行病学以及最新临床实践和台湾痛风以及高尿酸血症管理指南提出最新多学科专家共识。 , cover=, journalId=null, articlesId=null, associationId=1588, associationName=台湾多学科工作组（统称）, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 24 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>痛风是一种炎症性疾病，主要表现为在关节、软骨、滑膜囊、肌腱或软组织处沉积单钠晶体。本文主要基于台湾当地流行病学以及最新临床实践和台湾痛风以及高尿酸血症管理指南提出最新多学科专家共识。 </P> <P> </P>拓展指南：<STRONG>与<FONT color=red>痛风</FONT>相关指南：</STRONG><BR> <UL> <LI><A title=【干货】痛风病最权威的指南汇总 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=ce5591c001a4e8bb">【干货】痛风病最权威的指南汇总</A> <LI><A title="2017 BSR指南：痛风管理" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=5881f1c001a45481">2017 BSR指南：痛风管理</A> <LI><A title="2016 痛风治疗目标建议" target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=63b981c001a449e2">2016 痛风治疗目标建议</A> <LI><A title=2016年痛风治疗理念和治疗建议的更新 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=5172e1c001a255ab">2016年痛风治疗理念和治疗建议的更新</A> <LI><A title=2016中国痛风诊疗指南 target=_blank href="//m.capotfarm.com/guideline/show_article.do?id=78bd71c001355944">2016中国痛风诊疗指南</A> 更多信息请点击：<A target=_blank href="//m.capotfarm.com/guideline/list.do?q=%E7%97%9B%E9%A3%8E">有关痛风更多指南</A></LI></UL>, tagList=[TagDto(tagId=1530, tagName=痛风), TagDto(tagId=4057, tagName=高尿酸血症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10013, appHits=1472, showAppHits=18, pcHits=5711, showPcHits=3762, likes=194, shares=48, comments=6, approvalStatus=1, publishedTime=Mon Jan 29 18:10:21 CST 2018, publishedTimeString=2018-01-24, pcVisible=1, appVisible=1, editorId=5552845, editor=_Shirley_, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 29 18:10:21 CST 2018, updatedBy=5552845, updatedName=_Shirley_, updatedTime=Fri Jan 05 21:43:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 台湾多学科共识：痛风及高尿酸血症的管理)])
2018 台湾多学科共识：痛风及高尿酸血症的管理
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1009609, encodeId=81431009609f5, content=thank you, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/0c4788fb16f54223b1f865b8d0b0ed70/7e053d2497ee4fe1a33b24decc802ad9.jpg, createdBy=215b5579032, createdName=ms4000000062900195, createdTime=Fri Aug 20 07:43:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960869, encodeId=a9b7960869c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/49f98deeb83643dea0a56dbbc3f9428e/2dd23f66024542cd8e5d549725629143.jpg, createdBy=3cfa1712572, createdName=bigsteam, createdTime=Tue Apr 27 09:51:44 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891038, encodeId=de5e891038f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Sat Oct 10 11:51:22 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284996, encodeId=1ea02849968f, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Feb 04 09:42:21 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283502, encodeId=d655283502fd, content=诊疗进展值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2021-08-20 ms4000000062900195

    thank you

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1009609, encodeId=81431009609f5, content=thank you, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/0c4788fb16f54223b1f865b8d0b0ed70/7e053d2497ee4fe1a33b24decc802ad9.jpg, createdBy=215b5579032, createdName=ms4000000062900195, createdTime=Fri Aug 20 07:43:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960869, encodeId=a9b7960869c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/49f98deeb83643dea0a56dbbc3f9428e/2dd23f66024542cd8e5d549725629143.jpg, createdBy=3cfa1712572, createdName=bigsteam, createdTime=Tue Apr 27 09:51:44 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891038, encodeId=de5e891038f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Sat Oct 10 11:51:22 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284996, encodeId=1ea02849968f, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Feb 04 09:42:21 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283502, encodeId=d655283502fd, content=诊疗进展值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2021-04-27 bigsteam

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1009609, encodeId=81431009609f5, content=thank you, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/0c4788fb16f54223b1f865b8d0b0ed70/7e053d2497ee4fe1a33b24decc802ad9.jpg, createdBy=215b5579032, createdName=ms4000000062900195, createdTime=Fri Aug 20 07:43:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960869, encodeId=a9b7960869c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/49f98deeb83643dea0a56dbbc3f9428e/2dd23f66024542cd8e5d549725629143.jpg, createdBy=3cfa1712572, createdName=bigsteam, createdTime=Tue Apr 27 09:51:44 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891038, encodeId=de5e891038f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Sat Oct 10 11:51:22 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284996, encodeId=1ea02849968f, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Feb 04 09:42:21 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283502, encodeId=d655283502fd, content=诊疗进展值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2020-10-10 ms5000002046462755

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1009609, encodeId=81431009609f5, content=thank you, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/0c4788fb16f54223b1f865b8d0b0ed70/7e053d2497ee4fe1a33b24decc802ad9.jpg, createdBy=215b5579032, createdName=ms4000000062900195, createdTime=Fri Aug 20 07:43:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960869, encodeId=a9b7960869c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/49f98deeb83643dea0a56dbbc3f9428e/2dd23f66024542cd8e5d549725629143.jpg, createdBy=3cfa1712572, createdName=bigsteam, createdTime=Tue Apr 27 09:51:44 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891038, encodeId=de5e891038f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Sat Oct 10 11:51:22 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284996, encodeId=1ea02849968f, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Feb 04 09:42:21 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283502, encodeId=d655283502fd, content=诊疗进展值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2018-02-04 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1009609, encodeId=81431009609f5, content=thank you, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210820/0c4788fb16f54223b1f865b8d0b0ed70/7e053d2497ee4fe1a33b24decc802ad9.jpg, createdBy=215b5579032, createdName=ms4000000062900195, createdTime=Fri Aug 20 07:43:11 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960869, encodeId=a9b7960869c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210427/49f98deeb83643dea0a56dbbc3f9428e/2dd23f66024542cd8e5d549725629143.jpg, createdBy=3cfa1712572, createdName=bigsteam, createdTime=Tue Apr 27 09:51:44 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891038, encodeId=de5e891038f7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Sat Oct 10 11:51:22 CST 2020, time=2020-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284996, encodeId=1ea02849968f, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sun Feb 04 09:42:21 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=283502, encodeId=d655283502fd, content=诊疗进展值得借鉴, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Tue Jan 30 11:58:00 CST 2018, time=2018-01-30, status=1, ipAttribution=)]
    2018-01-30 虈亣靌

    诊疗进展值得借鉴

    0

相关指南

中国高尿酸血症相关疾病诊疗多学科专家共识

肾脏病相关专家小组（统称） · 2017-03-30

【干货】痛风病最权威的指南汇总

暂未更新 · 2017-06-05

2017 BSR指南：痛风管理

暂未更新 · 2017-05-26

2016 痛风治疗目标建议

国外风湿免疫科相关专家小组 · 2016-04-01

2016年痛风治疗理念和治疗建议的更新

暂未更新 · 2017-03-30

2016 ACP临床实践指南：急性和复发性痛风的管理

美国医师协会(ACP,American College of Physicians) · 2016-11-01

Baidu
map
Baidu
map
Baidu
map